SCHEMBL11297375

SCHEMBL11297375

O=C(NO)c1ccc(N(c2ccc(C(F)(F)F)cc2)C2CCNC2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 8/20 0.44
▸ HDAC6 Q9UBN7 7/20 0.44
▸ HDAC1 Q13547 4/20 0.44
▸ HDAC3 O15379 3/20 0.40
▸ GPR6 P46095 1/20 0.40
▸ HDAC11 Q96DB2 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ ADAM17 P78536 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11300469 0.90 HDAC6 (0.47) HDAC8HDAC6HDAC1HDAC3HDAC11
SCHEMBL11305647 0.89 HDAC6 (0.41) HDAC8HDAC6HDAC1HDAC3GPR6
SCHEMBL11301754 0.86 PSEN1 (0.42) HDAC8HDAC6HDAC1HDAC2
SCHEMBL11296049 0.84 HDAC6 (0.45) HDAC8HDAC6HDAC1KDM4EMEN1
SCHEMBL11303328 0.83 HDAC8 (0.37) HDAC8HDAC6HDAC1KDM4EMEN1
SCHEMBL11299083 0.83 HDAC6 (0.42) HDAC8HDAC6HDAC1HDAC3HDAC2
SCHEMBL11302647 0.83 HDAC6 (0.43) HDAC8HDAC6HDAC1GPR6HDAC11
SCHEMBL11296107 0.82 HDAC8 (0.45) HDAC8HDAC6HDAC1HDAC3KMT2A
SCHEMBL11296595 0.82 HDAC6 (0.42) HDAC8HDAC6HDAC1HDAC3HDAC11
SCHEMBL11303268 0.82 ABL1 (0.37) HDAC8HDAC6HDAC1HDAC3RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback